These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 19173804)
1. [Expressions of Fas, CTLA-4 and RhoBTB2 genes in breast carcinoma and their relationship with clinicopathological factors]. Bi Y; Wei L; Mao HT; Zhang L; Zuo WS Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):749-53. PubMed ID: 19173804 [TBL] [Abstract][Full Text] [Related]
2. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer. Mao H; Qu X; Yang Y; Zuo W; Bi Y; Zhou C; Yin H; Deng B; Sun J; Zhang L Mol Carcinog; 2010 Mar; 49(3):283-9. PubMed ID: 19937980 [TBL] [Abstract][Full Text] [Related]
3. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast]. Yang M; Xu SP; Ao QL Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534 [TBL] [Abstract][Full Text] [Related]
4. RhoBTB2 gene in breast cancer is silenced by promoter methylation. Tang W; Wang C; Fu F; Chen Q Int J Mol Med; 2014 Mar; 33(3):722-8. PubMed ID: 24356943 [TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of LRP16 gene in human breast cancer]. Liao DX; Han WD; Zhao YL; Pu YD; Mu YM; Luo CH; Li XH Ai Zheng; 2006 Jul; 25(7):866-70. PubMed ID: 16831279 [TBL] [Abstract][Full Text] [Related]
6. [Study of HOXA5 gene expression in breast carcinoma]. Zeng Y; Yang WT; Zhang GH; Zhu XZ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):569-74. PubMed ID: 16468307 [TBL] [Abstract][Full Text] [Related]
7. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization. Vinatzer U; Dampier B; Streubel B; Pacher M; Seewald MJ; Stratowa C; Kaserer K; Schreiber M Clin Cancer Res; 2005 Dec; 11(23):8348-57. PubMed ID: 16322295 [TBL] [Abstract][Full Text] [Related]
8. [Abnormal expression of RSK-4 and its clinical significance in breast cancer]. Liu JL; Yang HW; Chen ZS; Jiang Y Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):452-6. PubMed ID: 21875487 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients. He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408 [TBL] [Abstract][Full Text] [Related]
10. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance]. Ma YH; Wang K; Li L; Lu ZH; Chen J Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391 [TBL] [Abstract][Full Text] [Related]
11. [The clinical significance of P-glycoprotein, lung resistance protein and multidrug resistance related protein expressions in infiltrating breast carcinoma tissues]. Zuo WS; Wei L; Song XR; Wang XW; Wang MY; Wang YS; Yu ZY; Bi Y Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3142-5. PubMed ID: 17313768 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of GLTSCR2 expression is correlated with breast cancer progression. Moon A; Lim SJ; Jo YH; Lee S; Kim JY; Lee J; Park JH Pathol Res Pract; 2013 Nov; 209(11):700-4. PubMed ID: 24054033 [TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients. Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527 [TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of KNSL4 in breast cancer]. Feng YM; Wan YF; Li XQ; Cao XC; Li X Ai Zheng; 2006 Jun; 25(6):744-8. PubMed ID: 16764773 [TBL] [Abstract][Full Text] [Related]
15. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast. Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261 [TBL] [Abstract][Full Text] [Related]
16. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis]. Zhang B; Liu FF; Ma YJ; Gu F Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959 [TBL] [Abstract][Full Text] [Related]
17. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas. Kassardjian A; Shintaku PI; Moatamed NA PLoS One; 2018; 13(4):e0195958. PubMed ID: 29672601 [TBL] [Abstract][Full Text] [Related]
18. [Flow cytometric quantitative analysis of multiple tumor suppressor gene 1 (MTS1) and cyclooxygenase-2 (COX-2) gene expressions in invasive breast cancers and their clinical significance]. Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY; Bi Y; Liu YS; Zhou ZB Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):515-7. PubMed ID: 17147116 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between SLP-2 expression and prognosis in laryngeal squamous cell carcinoma and mammary invasive carcinoma]. Cao WF; Zhang LY; Zhang B; Liu MB; Liu ZH; Sun BC Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):332-7. PubMed ID: 20654157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]